Keylika (Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$12,000,000
Company Info
Founders
Buddha Chaudhuri
Market
Healthcare & Wellness
Coinvestors
Y Combinator
Company Description

An early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. Keylika developed a platform synthesis technology that is used to generate multitude of organometallic drugs.